Article,

Evolving understanding of translocator protein 18 kDa (TSPO)

, , , and .
Pharmacological Research, (2015)
DOI: http://dx.doi.org/10.1016/j.phrs.2015.03.022

Abstract

Abstract The translocator protein 18 kDa (TSPO) has been the focus of intense research by the biomedical community and the pharmaceutical industry because of its apparent involvement in many disease-related processes. These include steroidogenesis, apoptosis, inflammation, neurological disease and cancer, resulting in the use of \TSPO\ as a biomarker and its potential as a drug target. Despite more than 30 years of study, the precise function of \TSPO\ remains elusive. A recent breakthrough in determining the high-resolution crystal structures of bacterial homologs of mitochondrial \TSPO\ provides new insight into the structural and functional properties at a molecular level and new opportunities for investigating the significance of this ancient and highly conserved protein family. The availability of atomic level structural information from different species also provides a platform for structure-based drug development. Here we briefly review current knowledge regarding \TSPO\ and the implications of the new structures with respect to hypotheses and controversies in the field.

Tags

Users

  • @salotz

Comments and Reviews